Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children.
Bastard P,Gervais A,Taniguchi M,Saare L,Särekannu K,Le Voyer T,Philippot Q,Rosain J,Bizien L,Asano T,Garcia-Prat M,Parra-Martínez A,Migaud M,Tsumura M,Conti F,Belot A,Rivière J,Morio T,Tanaka J,Javouhey E,Haerynck F,Duvlis S,Ozcelik T,Keles S,Tandjaoui-Lambiotte Y,Escoda S,Husain M,Pan-Hammarström Q,Hammarström L,Ahlijah G,Abi Haidar A,Soudee C,Arseguel V,Abolhassani H,Sahanic S,Tancevski I,Nukui Y,Hayakawa S,Chrousos G,Michos A,Tatsi E,Filippatos F,Rodriguez-Palmero A,Troya J,Tipu I,Meyts I,Roussel L,Ostrowski S,Schidlowski L,Prando C,Condino-Neto A,Cheikh N,Bousfiha A,El Bakkouri J,Peterson P,Pujol A,Lévy R,Quartier P,Vinh D,Boisson B,Béziat V,Zhang S,Borghesi A,Pession A,Andreakos E,Marr N,Mentis A,Mogensen T,Rodríguez-Gallego C,Soler-Palacin P,Colobran R,Tillmann V,Neven B,Trouillet-Assant S,Brodin P,Abel L,Jouanguy E,Zhang Q,Martinón-Torres F,Salas A,Gómez-Carballa A,Gonzalez-Granado L,Kisand K,Okada S,Puel A,Cobat A,Casanova J
Source :
Pmid / DOI: